ARTICLE | Company News

Genesis Bioventures, Prion Developmental Laboratories Inc. deal

December 4, 2000 8:00 AM UTC

BILB made a second $1 million investment in Prion, which is developing diagnostics to detect prion-based diseases such as Creutzfeld-Jacob, or "Mad Cow" disease. BILB, which changed its name last week from BioLabs Inc., owns 25 percent of Prion following the investment. ...